In a previous analysis of HNSCC, there was no observable effect of p16, MGMT, DAPK, or E-cadherin on prognosis for patients with laryngeal and hypopharyngeal cancer [8]. This evidence concerns the gene MGMT and head and neck squamous cell carcinoma.